Genetics of Recurrent Early-Onset Depression
This nationwide study will create a DNA collection to permit qualified scientists to search for depression-related genes.
More than 750 families with at least two siblings who have experienced major depression are needed for the study. Participants will be interviewed about psychiatric and family history, and will be asked to provide a small blood specimen. The identification of predisposing genes can lead to greater understanding of the brain mechanisms involved in severe depression which can in turn lead to the discovery of new treatments.
A Certificate of Confidentiality from the federal government ensures that all information will be strictly confidential. Blood specimens are identified only by code number (not by name).
Reimbursement is provided.
|Study Design:||Time Perspective: Retrospective|
|Study Start Date:||October 1999|
|Estimated Study Completion Date:||September 2003|
Studies of patterns of major depression in families suggest that 50 to 70% of the predisposition to major depression is caused by genes. People with recurrent depression and earlier ages of onset have more relatives with depression. There are probably at least several interacting genes, rather than a single gene as in some disorders. The identification of predisposing genes is likely to lead to greater understanding of the brain mechanisms involved in severe depression. This could lead to the discovery of new treatments.
This study will create a DNA collection to permit qualified scientists to search for depression-related genes. More than 750 families with at least two siblings who have experienced major depression are needed for the study.
Participants in this study will be interviewed about psychiatric and family history, and will be asked for a small blood specimen. Interviews can be conducted in person or by telephone. For telephone interviews, blood sample collection will be arranged at a location and time convenient for the participant. Participants will also be asked for help in inviting other family members to participate. No family member will be contacted without the permission and assistance of another participating family member.
For information on a related study, please follow this link:
Please refer to this study by its ClinicalTrials.gov identifier: NCT00005914
|United States, Illinois|
|Rush Presbyterian - Saint Luke's Med Ctr|
|Chicago, Illinois, United States, 60612|
|United States, Iowa|
|Univ of Iowa Hosp and Clinic|
|Iowa City, Iowa, United States, 52242|
|United States, Maryland|
|Johns Hopkins University|
|Baltimore, Maryland, United States, 21287-7381|
|United States, New York|
|New York State Psychiatric Institute / Columbia Univ|
|New York, New York, United States, 10032|
|United States, Pennsylvania|
|Univ of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104-2648|
|Univ of Pittsburgh / Western Psychiatric Inst and Clinic|
|Pittsburgh, Pennsylvania, United States, 15213|
|Principal Investigator:||Myrna Weissman|
|Principal Investigator:||J Raymond DePaulo|
|Principal Investigator:||William Scheftner|
|Principal Investigator:||Raymond Crowe|
|Principal Investigator:||Douglas Levinson|
|Principal Investigator:||George Zubenko|